Furthermore, the intrinsic PD-L1/NLRP3 pathway had been reported in the previous studies [31, 32], and we validated that low-dose DB inhibited PD-L1 expressions to activate NLRP3 mediated cell pyroptosis in cisplatin treated CR-GC cells. The gene discussed is CD274; the disease is gastric cancer.